PainReform Ltd. (NASDAQ:PRFX) Stock Falls Without Any News: Will It Rebound?

August 2, 2021

PainReform Ltd. (NASDAQ:PRFX) dropped 17% after a recent jump despite the company not releasing any news.  The company focuses on established drugs reformulation with an extended-release system vital in minimizing post-surgical pain. Retail traders in social media platforms have been citing PRFX’s low float as a catalyst to spur up momentum. That added to the speculation that PainReform is almost releasing its third Phase PRF-110 clinical trials results could be…